Make an Appointment
To speak with a member of our Urology team, please call us.
Welcome to Lahey Hospital & Medical Center’s Institute of Urology, where we have earned a reputation as an international leader in the field of urology, noted for both clinical and academic excellence.
Our urologists work together to develop customized treatment plans, ensuring exceptional care and the best possible outcomes. We offer minimally invasive and robotic surgery procedures for many urologic conditions, such as prostate cancer, bladder cancer and more.
The Institute of Urology is a major tertiary referral center for the treatment of urologic disease. Many patients with difficult urologic conditions are referred to us by other urologists for complex operations.
Our staff consists of subspecialty-trained urologists with busy outpatient practices who perform inpatient and ambulatory surgical procedures. We have specialized expertise in:
Lahey offers medical education to both residents and fellows. LHMC is a Teaching Hospital of Tufts University School of Medicine.
Lahey Hospital and Medical Center’s Urology Residency Program is a 5-year training program that accepts 3 residents per year. Our residents rotate at hospitals that accommodate outpatient clinics and operating rooms under one roof, allowing trainees to participate in outpatient evaluation, operative procedures, post-operative care and hospital follow-up.
The Center for Reconstructive Urologic Surgery offers New England’s only Male Genitourinary Reconstructive Urologic Surgery Fellowship. The fellowship is a one year clinical position, designed to provide expertise in adult male reconstructive urology.
Lahey Hospital & Medical Center’s Institute of Urology is committed to research and clinical trials to find better ways to prevent, diagnose and treat urologic cancers.
Search our database of clinical trials at Lahey Hospital & Medical Center that are related to urologic cancer.
The Lahey Institute of Urology has evaluated The OPKO Diagnostics 4Kscore in predicting the diagnosis of prostate cancer prior to prostate biopsy. This molecular assay may be helpful in determining the likelihood that a patient with a prior negative prostate biopsy will be diagnosed with cancer on repeat biopsy.
These molecular-based strategies in patient care are designed to benefit patients and assist urologists in selecting patients appropriately for prostate biopsy.
We also are collaborating in clinical trials of dietary supplements that hold promise in prostate cancer chemoprevention.
We are currently collaborating in clinical trials of molecular-targeted therapies and dietary supplements that hold promise in the prevention of diagnosis, recurrence and/or progression of bladder cancer.
The Lahey Institute of Urology is privileged to have a Urologic Oncology Research Laboratory headed by Kimberly Rieger-Christ, PhD. Dr. Reiger-Christ is a senior scientist in the Institute of Urology and the Sophia Gordon Cancer Center at Lahey Hospital & Medical Center and holds an academic position as an Assistant Professor at Tufts University Medical School.
She joined Lahey Clinic in 1998, where she has partnered in building the research program. For the past 10 years she has overseen the urology residents’ research program and conducted the oversight of research within the urology department.
The lab allows for translational research focused on various biologic markers for bladder and prostate cancer. These efforts open the possibility of taking cutting-edge research from the laboratory to assess and evaluate prognostic markers along with therapeutics for our patients.
We offer expert care through our specialty centers:
Lahey Hospital & Medical Center is proud to offer urologic care at several locations in northeastern Massachusetts and southern New Hampshire.